Advanced Circulatory Systems Secures Additional $1.5 Million From NIH
Posted on: Tuesday, 14 October 2008, 09:00 CDT
Advanced Circulatory Systems, a privately held healthcare company, has received an additional $1.5 million in funding from the National Institutes of Health to continue a study testing two devices used in combination on those who experience cardiac arrest outside a hospital.
The National Institutes of Health (NIH) funding will be used to increase enrollment in the six-site study. The study involves the testing of the ResQPump, an active compression or decompression device, in combination with the ResQPOD, a device used to increase blood flow to the heart and brain during cardiopulmonary resuscitation (CPR).
The current NIH funded study is the first randomized study in the US to assess results of the ResQPump and ResQPOD used together and comparing results when CPR is performed without these devices. Minneapolis and St Paul are two of six sites included in the national study.
The ResQPump has been tested and is currently in use in Europe. Both devices are designed and manufactured by Advanced Circulatory Systems of Minneapolis, Minnesota.
Source: Datamonitor
Related Articles
- Heart risk rising in younger Canadians
- Raytheon Wins NextGen Contract to Study National Airspace System Needs
- Consumer Group Releases New Study About Defective Heart Devices and Implants; Patients Arrive in DC Tomorrow
- Kids With Limited Video Become Less Obese
- Cardiovascular Associates Participating in Clinical Study to Evaluate First-in-Class Cardiac Device
- Early Puberty: Greater Risk for Sex, Drugs
- RITA Medical Initiates Feasibility Study of Device for RFA-Assisted Breast Lumpectomy
- Study: Cardiac Device Testing Low Risk
- New Device Helps GERD Patients
- Studies Shows Device-Guided Paced Breathing Lowers Blood Pressure & Peripheral Resistance; RESPeRATE(R) Demonstrates Sustained Effect on Blood Vessels
 |
 |
User Comments (0)
RSS Feeds